Bharat Immunologicals & Biologicals (BOM:524663) Debt-to-Asset : 0.40 (As of Sep. 2023)

Bharat Immunologicals & Biologicals Debt-to-Asset Chart

Bharat Immunologicals & Biologicals Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
Debt-to-Asset		Get a 7-Day Free Trial					0.26	0.02	0.26	0.37	0.37

Bharat Immunologicals & Biologicals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Debt-to-Asset	Get a 7-Day Free Trial															0.38	-	0.37	-	0.40

Competitive Comparison of Bharat Immunologicals & Biologicals's Debt-to-Asset

For the Biotechnology subindustry, Bharat Immunologicals & Biologicals's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bharat Immunologicals & Biologicals's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bharat Immunologicals & Biologicals's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Bharat Immunologicals & Biologicals's Debt-to-Asset falls into.

Bharat Immunologicals & Biologicals Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Bharat Immunologicals & Biologicals's Debt-to-Asset for the fiscal year that ended in Mar. 2023 is calculated as

Bharat Immunologicals & Biologicals's Debt-to-Asset for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bharat Immunologicals & Biologicals  (BOM:524663) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Bharat Immunologicals & Biologicals Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Bharat Immunologicals & Biologicals's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Bharat Immunologicals & Biologicals (BOM:524663) Business Description